|
|||||
|
|
Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Hemoperitoneum in Patients With Cirrhosis |
|
| Authors: | Farid Abushamat MD Christoph F. Dietrich MD MBA Dirk-Andre Clevert MD Fabio Piscaglia MD PhD David T. Fetzer MD Maria Franca Meloni MD Masoud Shiehmorteza MD Yuko Kono MD PhD |
| Affiliation: | 1. University of California San Diego, San Diego, CA, USA;2. Clinic Hirslanden Bern Beau Site, Bern, Switzerland;3. University of Munich-Grosshadern Campus, Munich, Germany;4. Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;5. UT Southwestern Medical Center, Dallas, TX, USA;6. University of Milan-Bicocca, Milan, Italy |
| Abstract: | Hemoperitoneum in cirrhosis is a life-threatening condition that requires emergent evaluation. Contrast-enhanced ultrasound (CEUS) permits multiple dynamic characterizations of abdominal structures through all vascular phases, and contrast extravasation or the presence of microbubbles in the ascites could be a sensitive tool. We reviewed 13 patients with cirrhosis that underwent CEUS due to high suspicion for intra-abdominal bleeding. In 10 cases, CEUS demonstrated extravasation of contrast, including 2 instances where CEUS detected active bleeding despite negative computed tomography. These data support further study of CEUS in direct comparison to other imaging modalities in this clinical context. |
| Keywords: | CEUS cirrhosis bleeding hemoperitoneum |